541513-52-4

Basic information

• Product Name: (4R)-4-benzyl-3-{(2R,3S)-4-[(1S)-2,2-dimethyl-[1,3]-dioxolan-4-yl]-3-hydroxy-2-methylbutyryl}oxazolidin-2-one
• Synonyms: (4R)-4-benzyl-3-{(2R,3S)-4-[(1S)-2,2-dimethyl-[1,3]-dioxolan-4-yl]-3-hydroxy-2-methylbutyryl}oxazolidin-2-one
• CAS NO: 541513-52-4
• Molecular Weight: 377.437
• Mol File: 541513-52-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (4R)-4-benzyl-3-{(2R,3S)-4-[(1S)-2,2-dimethyl-[1,3]-dioxolan-4-yl]-3-hydroxy-2-methylbutyryl}oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (4R)-4-benzyl-3-{(2R,3S)-4-[(1S)-2,2-dimethyl-[1,3]-dioxolan-4-yl]-3-hydroxy-2-methylbutyryl}oxazolidin-2-one(541513-52-4)
• EPA Substance Registry System: (4R)-4-benzyl-3-{(2R,3S)-4-[(1S)-2,2-dimethyl-[1,3]-dioxolan-4-yl]-3-hydroxy-2-methylbutyryl}oxazolidin-2-one(541513-52-4)

Safety Data

• Hazardous Substances Data: 541513-52-4(Hazardous Substances Data)

Upstream product

• 32233-44-6 2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]acetaldehyde 
• 67-64-1 acetone 
• 541513-57-9 (4R)-4-benzyl-3-[(2R,3S)-3,5,6-trihydroxy-2-methylhexanoyl]oxazolidin-2-one 
• 101711-78-8 (3R)-3-propionyl-4-benzyloxazolidin-2-one 
• 95422-24-5 methyl (3S)-3,4-O-isopropylidene-3,4-dihydroxybutanoate 
• 126946-52-9 ethyl (3S)-3,4-dihydroxy-3,4-O-isopropylidene-butanoate 

Downstream Products

• 951154-69-1 5(S),7(S)-bis(tert-butyldimethylsilanyloxy)-10(S)-[2(R)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxan-4(S)-yl]-4(S)-methylundeca-2,8-dienoic acid ethyl ester 
• 951154-71-5 5(S),7(S)-bis(tert-butyldimethylsilanyloxy)-10(S)-[2(R)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxan-4(S)-yl]-4(S)-methylundeca-2,8-dien-1-ol 
• 951154-73-7 4(S)-[4(S),6(S)-bis(tert-butyldimethylsilanyloxy)-1(S),7(S)-dimethyl-10-trityloxydeca-2,8-dienyl]-2(R)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxane 
• 672296-38-7 (2S,3S,4S,7S,9S,10S)-7,9-bis(tert-butyldimethylsilanyloxy)-3-(4-methoxybenzyloxy)-2,4,10-trimethyl-13-trityloxytrideca-5,11-dien-1-ol 
• 672296-39-8 (4S,5S,6S,9S,11S,12S)-9,11-bis(tert-butyldimethylsilanyloxy)-5-(4-methoxybenzyloxy)-4,6,12-trimethyl-15-trityloxypentadeca-2,7,13-trienoic acid ethyl ester 
• 672296-40-1 (4S,5R,6S,9S,11S,12S)-9,11-bis(tert-butyldimethylsilanyloxy)-5-(4-methoxybenzyloxy)-4,6,12-trimethyl-15-trityloxypentadeca-7,13-dienoic acid ethyl ester 
• 672296-42-3 4(S)-benzyl-3-[9(S),11(S)-bis(tert-butyldimethylsilanyloxy)-5(R)-(4-methoxybenzyloxy)-4(S),6(S),12(S)-trimethyl-15-trityloxypentadeca-7,13-dienoyl]oxazolidin-2-one 
• 672296-41-2 C₅₇H₈₂O₇Si₂ 
• 672296-43-4 4(S)-benzyl-3-[9(S),11(S)-bis(tert-butyldimethylsilanyloxy)-5(R)-(4-methoxybenzyloxy)-2(S),4(S),6(S),12(S)-tetramethyl-15-trityloxy-pentadeca-7,13-dienoyl]oxazolidin-2-one 
• 672296-44-5 (2S,4S,5R,6S,9S,11S,12S)-9,11-bis(tert-butyldimethylsilanyloxy)-5-(4-methoxybenzyloxy)-2,4,6,12-tetramethyl-15-trityloxypentadeca-7,13-dien-1-ol 
• 672296-46-7 13(S),15(S)-bis(tert-butyldimethylsilanyloxy)-2(S)-[2(S)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxan-4(S)-yl]-9(R)-(4-methoxybenzyloxy)-6(S),8(S),10(S),16(S)-tetramethyl-19-trityloxynonadeca-4,11,17-trien-3-one 
• 672296-47-8 13(S),15(S)-bis(tert-butyldimethylsilanyloxy)-2(S)-[2(S)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxan-4(S)-yl]-9(R)-(4-methoxybenzyloxy)-6(R),8(S),10(S),16(S)-tetramethyl-19-trityloxynonadeca-11,17-dien-3-one 
• 951154-83-9 13(S),15(S)-bis(tert-butyldimethylsilanyloxy)-2(S)-[2(S)-(4-methoxyphenyl)-5(S)-methyl[1,3]dioxan-4(S)-yl]-9(R)-(4-methoxybenzyloxy)-6(R),8(S),10(S),16(S)-tetramethyl-19-trityloxynonadeca-11,17-dien-3(R)-ol 
• 951154-85-1 C₈₀H₁₂₂O₉Si₃ 

Relevant articles and documents

Synthesis and biological evaluation of (-)-dictyostatin and stereoisomers

Total syntheses of (-)-dictyostatin, 6,16-bis-epi-dictyostatin, 6,14,19-tris-epi-dictyostatin, and a number of other isomers and analogs are reported. Three main fragments-top, middle, and bottom-were first assembled and then joined by olefination or anio

Synthesis of (R)-2-methyl-4-deoxy and (R)-2-methyl-4,5-dideoxy analogues of 6-phosphogluconate as potential inhibitors of 6-phosphogluconate dehydrogenase.

The synthesis of (2R)-2-methyl-4,5-dideoxy and (2R)-2-methyl-4-deoxy analogues of 6-phosphogluconate is described. The synthetic strategy relies on the Evans aldol reaction for the installation of the chiral centres in the 2- and 3-positions. The selective phosphorylation at the primary alcohol function of (2R,3S)-3,6-dihydroxy-2-methylhexanoic acid benzyl ester (5) and (2R,3S,5S)-3,5,6-trihydroxy-2-methylhexanoic acid benzyl ester (20) was achieved with dibenzyl phosphochloridate and dibenzyl phosphoiodinate respectively, working at low temperature. (2R,3S)-3-Hydroxy-2-methyl-6-phosphonoxyhexanoic acid (9) was obtained in 25% overall yield from 4-benzyloxybutanol and (2R,3S,5S)-3,5-dihydroxy-2-methyl-6-phosphonoxyhexanoic acid (28) in 10% overall yield from L-malic acid.